Cencora Reports Q2 2026 Earnings with Revenue Growth and Raised Guidance
Cencora (COR) reported Q2 2026 earnings with adjusted diluted EPS of $4.75, a 7.5% increase, and raised full-year guidance to $17.65-$17.90 per share. Consolidated revenue reached $78.4 billion, up 4%, driven by growth in both U.S. and International Healthcare Solutions segments.
Tickers: $COR
Topics: acquisition earnings financial_performance guidance revenue